BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 23616088)

  • 1. Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology.
    Eisbach SE; Outeiro TF
    J Mol Med (Berl); 2013 Jun; 91(6):693-703. PubMed ID: 23616088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rab11 modulates α-synuclein-mediated defects in synaptic transmission and behaviour.
    Breda C; Nugent ML; Estranero JG; Kyriacou CP; Outeiro TF; Steinert JR; Giorgini F
    Hum Mol Genet; 2015 Feb; 24(4):1077-91. PubMed ID: 25305083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and Pathological Effects of α-Synuclein on Synaptic SNARE Complexes.
    Gao V; Briano JA; Komer LE; Burré J
    J Mol Biol; 2023 Jan; 435(1):167714. PubMed ID: 35787839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-synuclein and Parkinson's disease: the first roadblock.
    Chua CE; Tang BL
    J Cell Mol Med; 2006; 10(4):837-46. PubMed ID: 17125588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Transcellular Propagation and Intracellular Trafficking of α-Synuclein.
    Tofaris GK; Goedert M; Spillantini MG
    Cold Spring Harb Perspect Med; 2017 Sep; 7(9):. PubMed ID: 27920026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Synuclein: the long distance runner.
    George S; Rey NL; Reichenbach N; Steiner JA; Brundin P
    Brain Pathol; 2013 May; 23(3):350-7. PubMed ID: 23587141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease.
    Garcia-Reitböck P; Anichtchik O; Bellucci A; Iovino M; Ballini C; Fineberg E; Ghetti B; Della Corte L; Spano P; Tofaris GK; Goedert M; Spillantini MG
    Brain; 2010 Jul; 133(Pt 7):2032-44. PubMed ID: 20534649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snaring the function of alpha-synuclein.
    Bonini NM; Giasson BI
    Cell; 2005 Nov; 123(3):359-61. PubMed ID: 16269324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-Synuclein Nitration and Its Implications in Parkinson's Disease.
    He Y; Yu Z; Chen S
    ACS Chem Neurosci; 2019 Feb; 10(2):777-782. PubMed ID: 30183251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of RAB39B-Mediated Vesicular Trafficking in Lewy Body Diseases.
    Koss DJ; Campesan S; Giorgini F; Outeiro TF
    Mov Disord; 2021 Aug; 36(8):1744-1758. PubMed ID: 33939203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Synuclein in synaptic function and dysfunction.
    Sharma M; Burré J
    Trends Neurosci; 2023 Feb; 46(2):153-166. PubMed ID: 36567199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.
    Zhang S; Eitan E; Wu TY; Mattson MP
    Neurobiol Aging; 2018 Jan; 61():52-65. PubMed ID: 29035751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson's disease.
    Fonseca-Ornelas L; Viennet T; Rovere M; Jiang H; Liu L; Nuber S; Ericsson M; Arthanari H; Selkoe DJ
    Cell Rep; 2021 Jul; 36(1):109333. PubMed ID: 34233191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling.
    Sun J; Wang L; Bao H; Premi S; Das U; Chapman ER; Roy S
    Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11113-11115. PubMed ID: 31110017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.
    Jensen PH; Nielsen MS; Jakes R; Dotti CG; Goedert M
    J Biol Chem; 1998 Oct; 273(41):26292-4. PubMed ID: 9756856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
    Pozo Devoto VM; Falzone TL
    Dis Model Mech; 2017 Sep; 10(9):1075-1087. PubMed ID: 28883016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
    Schulz-Schaeffer WJ
    Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Aggregated Alpha Synuclein on Synaptic and Axonal Proteins in Parkinson's Disease-A Systematic Review.
    Murphy J; McKernan DP
    Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.